热门资讯> 正文
SBFM、BPATH和INDO均为上市前输家
2024-04-22 20:23
- Sunshine Biopharma Inc Ordinary Shares(SBFM) 0
- Bio-Path控股(BPTH) 0
- Indonesia Energy Corp Ltd.(INDO) 0
- Losers: Hepion Pharmaceuticals (HEPA) -38% initiates wind-down activities in Phase 2b ‘ASCEND-NASH’ trial.
- Top Wealth Group Holding Limited (TWG) -17%.
- Redwoods Acquisition Corp (RWOD) -13%.
- Sunshine Biopharma (SBFM) -12%.
- MediaCo Holding (MDIA) -11%.
- Indonesia Energy Corp Ltd (INDO) -11%.
- Bio-Path Holdings (BPTH) -9%.
- INVO Bioscience (INVO) -9%.
- Li Auto (LI) -7% shares slide after matching Tesla price cuts.
- Edible Garden (EDBL) -7%.
- Mobile health Network Solutions (MNDR) -3%.
- Endeavour Silver Corp. (EXK) -7% celebrates Milestone: Terronera surpasses 50% construction completion.
- Zhongchao (ZCMD) -6%.
- First Majestic Silver Corporation (AG) -6%.
- Coeur Mining (CDE) -6%.
- Hub Cyber Security Ltd (HUBC) -6%.
- Nova Lifestyle (NVFY) -6%.
- Harmony Gold Mining Co Ltd (HMY) -6%.
- Pan American Silver Corp (PAAS) -6%.
- Vizsla Silver Corp (VZLA) -6%.
- AngloGold Ashanti (AU) -6%.
- MAG Silver Corp. (MAG) -5%.
- Chromocell Therapeutics Corp. (CHRO) -5%.
More on pre-market losers & stocks.
- Bio-Path Holdings Inc. (BPTH) Q4 2023 Earnings Call Transcript
- Bio-Path announces $1.2M registered direct offering priced at-the-market
- Bio-Path shares rally after clinical trial progress of BP1002
- Seeking Alpha’s Quant Rating on Bio-Path
- Historical earnings data for Bio-Path
推荐文章
一周IPO丨中慧生物暗盘飙涨162%，中签一手赚超4000港元；“减肥药概念”银诺医药招股中
一周财经日历丨重磅财报周！腾讯京东季报轮番登场；美国7月CPI/PPI携手“恐怖数据”来袭
机器人投资风口来袭！世界级盛会催化下，哪些机会不容错过？
美股机会日报丨降息预期骤变！小摩称美联储年内或降息三次；SoundHound飙涨超27%
摩根大通预计美联储将在9月会议上降息25基点，接下来还会连续三次降息
英特尔首席执行官陈立武发文：关于过往职务信息有很多错误 董事会全力支持公司转型工作
美国养老金投资或迎巨变，特朗普颁令为401(k)纳入加密货币等资产铺路
外盘头条：OpenAI发布最强GPT-5；特朗普颁令允许养老金投资另类资产
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
